-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KZLsyIPcw+x4FXVYMwMEd5lbe6FGhZMuSCLwl1GLU/iBNKeuK4bwZ1KiZWgSAnYH VqfbOUfzS+pr3+rQW/EL3g== 0001362310-08-002876.txt : 20080516 0001362310-08-002876.hdr.sgml : 20080516 20080516172223 ACCESSION NUMBER: 0001362310-08-002876 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080516 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20080516 DATE AS OF CHANGE: 20080516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP CENTRAL INDEX KEY: 0000917520 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 510317849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1206 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-26224 FILM NUMBER: 08843307 BUSINESS ADDRESS: STREET 1: 311 C ENTERPRISE DRIVE CITY: PLAINSBORO STATE: NJ ZIP: 08536 BUSINESS PHONE: 6092750500 MAIL ADDRESS: STREET 1: 311 C ENTERPRISE DRIVE CITY: PLAINSBORO STATE: NJ ZIP: 08536 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP DATE OF NAME CHANGE: 19950614 8-K 1 c73456e8vk.htm FORM 8-K Filed by Bowne Pure Compliance
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 16, 2008

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
(Exact name of registrant as specified in its charter)
         
Delaware   0-26224   51-0317849
(State or other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)
     
311 Enterprise Drive
Plainsboro, NJ
  08536
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (609) 275-0500
 
Not Applicable
(Former name or former address if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 

1


 

ITEM 8.01 OTHER EVENTS

On May 16, 2008, Integra LifeSciences Holdings Corporation issued a press release announcing that it has scheduled a conference call for 9:00 AM EDT on Monday, May 19, 2008, to discuss its financial results for the fourth quarter and year ended December 31, 2007 and to update forward-looking financial guidance.

Access to the live call is available by dialing 913-312-0863 or through a webcast via a link provided on the Investor Relations homepage of Integra’s website at www.Integra-LS.com. Access to a replay is available through May 26, 2008 by dialing 719-457-0820 (PIN 4115546) or through the webcast.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibits

99.1        Press release, dated May 16, 2008, issued by Integra LifeSciences Holdings Corporation

 

2


 

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
         
     
Date: May 16, 2008  By:   /s/ Stuart M. Essig    
    Stuart M. Essig   
    Title:   President and Chief Executive Officer   
 

 

 


 

EXHIBIT INDEX
     
Exhibit No.   Description
99.1
  Press Release, dated May 16, 2008, issued by Integra LifeSciences Holdings Corporation.

 

 

EX-99.1 2 c73456exv99w1.htm EXHIBIT 99.1 Filed by Bowne Pure Compliance
Exhibit 99.1
News Release
Contact:
Integra LifeSciences Holdings Corporation
     
John B. Henneman III
  Karen Mroz-Bremner
Executive Vice President, Finance and Administration
  Senior Manager, Corporate Development
Chief Financial Officer
  and Investor Relations
(609) 936-2481
  (609) 936-6929
jhenneman@Integra-LS.com
  karen.mroz-bremner@Integra-LS.com
Integra LifeSciences to Host 2007 Financial Results Conference Call on May 19
Plainsboro, New Jersey, May 16, 2008— Integra LifeSciences Holdings Corporation (NASDAQ:IART) has scheduled a conference call for 9:00 AM EDT on Monday, May 19, 2008 to discuss financial results for the fourth quarter and full year ended December 31, 2007 and to update forward-looking financial guidance. Financial results for the fourth quarter and full year 2007 will be announced via a news release prior to the conference call.
The conference call will be hosted by Stuart Essig, President and Chief Executive Officer of Integra, and will be open to all listeners. Additional forward-looking information may be discussed in a question and answer session following the call.
Access to the live call is available by dialing 913-312-0863 or through a webcast via a link provided on the Investor Relations homepage of Integra’s website at www.Integra-LS.com. Access to a replay is available through May 26, 2008 by dialing 719-457-0820 (PIN 4115546) or through the webcast.
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is dedicated to improving the quality of life for patients through the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments. Our products are used primarily in neurosurgery, extremity reconstruction, orthopedics and general surgery to treat millions of patients every year. Integra’s headquarters are in Plainsboro, New Jersey, and we have research and manufacturing facilities throughout the world. Please visit our website at (http://www.Integra-LS.com).
IART-G
Source: Integra LifeSciences Holdings Corporation

 

 

-----END PRIVACY-ENHANCED MESSAGE-----